SEC Form 4 · accession 0001209191-15-004057
KERYX BIOPHARMACEUTICALS INC · KERX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Greg Madison
Officer — President and COO
Period of report
Jan 11, 2015
Accepted (ET)
Jan 13, 2015 · 9:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $14.68 | Jan 11, 2015 | A | 400,000 | A | Jan 11, 2016 | Jan 11, 2025 | Common Stock | 400,000 | 662,750 | D |
Explanation of responses
- F1The options vest according to the following schedule: one-third of the 400,000 options will vest on January 11, 2016, and one-twelfth will vest on each of April 11, 2016, July 11, 2016, October 11, 2016, January 11, 2017, April 11, 2017, July 11, 2017, October 11, 2017, and January 11, 2018.